• Cantrell, J.E., Phillips, T.M. & Schein, P.S. (1985) Carcinoma-associated hemolytic–uremic syndrome: a complication of mitomycin C chemotherapy. Journal of Clinical Oncology, 3, 723734.
  • Fisher, D.C., Sherrill, G.B., Hussein, A., Rubin, P., Vredenburgh, J.J., Elkordy, M., Ross, M., Petros, W. & Peters, W.P. (1996) Thrombotic microangiopathy as complication of high-dose chemotherapy for breast cancer. Bone Marrow Transplantation, 18, 193198.
  • Furlan, M., Robles, R., Solenthaler, M., Wassmer, M., Sandoz, P. & Lämmle, B. (1997) Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood, 89, 30973103.
  • Furlan, M., Robles, R., Solenthaler, M. & Lämmle, B. (1998a) Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura. Blood, 91, 28392846.
  • Furlan, M., Robles, R., Galbusera, M., Remuzzi, G., Kyrle, P.A., Brenner, B., Krause, M., Scharrer, I., Aumann, V., Mittler, U., Solenthaler, M. & Lämmle, B. (1998b) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic–uremic syndrome. New England Journal of Medicine, 339, 15781584.DOI: 10.1056/NEJM199811263392202
  • Gerritsen, H.E., Turecek, P.L., Schwarz, H.P., Lämmle, B. & Furlan, M. (1999) Assay of von Willebrand factor (vWF) -cleaving protease based on decreased collagen binding affinity of degraded vWF. A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Thrombosis and Haemostasis, 82, 13861389.
  • Gordon, L.I. & Kwaan, H.C. (1999) Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Seminars in Thrombosis and Hemostasis, 25, 217221.
  • Moake, J.L. & Chow, T.W. (1998) Thrombotic thrombocytopenic purpura: understanding a disease no longer rare. American Journal of the Medical Sciences, 316, 105119.DOI: 10.1097/00000441-199808000-00006
  • Montes, A., Powles, T.J., O'Brien, M.E., Ashley, S.E., Luckit, J. & Treleaven, J. (1993) A toxic interaction between mitomycin C and tamoxifen causing the hemolytic uremic syndrome. European Journal of Cancer, 29A, 18541857.DOI: 10.1016/0959-8049(93)90537-P
  • Moore, J.C., Murphy, G.M. & Kelton, J.G. (1990) Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. British Journal of Haematology, 74, 457464.
  • Oleksowicz, L., Bhagwati, N. & DeLeon-Fernandez, M. (1999) Deficient activity of von Willebrand′ s factor-cleaving protease in patients with disseminated malignancies. Cancer Research, 59, 22442250.
  • Tsai, H.M. & Lian, E.C. (1998) Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. New England Journal of Medicine, 339, 15851594.DOI: 10.1056/NEJM199811263392203